These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 37307224)
41. An update on pharmaceutical film coating for drug delivery. Felton LA; Porter SC Expert Opin Drug Deliv; 2013 Apr; 10(4):421-35. PubMed ID: 23339342 [TBL] [Abstract][Full Text] [Related]
42. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs? Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469 [TBL] [Abstract][Full Text] [Related]
43. Biopharmaceutical aspects and implications of excipient variability in drug product performance. Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182 [TBL] [Abstract][Full Text] [Related]
44. Promises of Molecular Pharmaceutics in the Development of Novel Drug Delivery Formulations. Kumar P; Chaudhary B; Jain V; Baboota S; Shivanandy P; Alharbi KS; Ghoneim MM; Alshehri S; Imam SS; Gupta G; Gupta MM Curr Drug Deliv; 2023; 20(9):1262-1274. PubMed ID: 36380413 [TBL] [Abstract][Full Text] [Related]
45. Can Pharmaceutical Excipients Threaten the Aquatic Environment? A Risk Assessment Based on the Microtox Turek M; Różycka-Sokołowska E; Koprowski M; Marciniak B; Bałczewski P Molecules; 2023 Sep; 28(18):. PubMed ID: 37764366 [TBL] [Abstract][Full Text] [Related]
46. Issues in the formulation of drugs for oral use in children: role of excipients. Pawar S; Kumar A Paediatr Drugs; 2002; 4(6):371-9. PubMed ID: 12038873 [TBL] [Abstract][Full Text] [Related]
47. Gamma sterilization of pharmaceuticals--a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations. Hasanain F; Guenther K; Mullett WM; Craven E PDA J Pharm Sci Technol; 2014; 68(2):113-37. PubMed ID: 24668600 [TBL] [Abstract][Full Text] [Related]
48. Manipulation of Pharmaceutical Polymorphic Transformation Process Using Excipients. Tian B; Ding Z; Zong S; Yang J; Wang N; Wang T; Huang X; Hao H Curr Pharm Des; 2020; 26(21):2553-2563. PubMed ID: 32053064 [TBL] [Abstract][Full Text] [Related]
49. Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism. Dikeocha IJ; Al-Kabsi AM; Miftahussurur M; Alshawsh MA FASEB J; 2022 Jun; 36(6):e22350. PubMed ID: 35579628 [TBL] [Abstract][Full Text] [Related]
50. Application of co-processed excipients for developing fast disintegrating tablets: A review. Jain S; Kaur S; Rathi R; Nagaich U; Singh I Polim Med; 2023; 53(1):59-68. PubMed ID: 36929642 [TBL] [Abstract][Full Text] [Related]
52. Role of the gut microbiome in cardiovascular drug response: The potential for clinical application. Steiner HE; Gee K; Giles J; Knight H; Hurwitz BL; Karnes JH Pharmacotherapy; 2022 Feb; 42(2):165-176. PubMed ID: 34820870 [TBL] [Abstract][Full Text] [Related]
56. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I). Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089 [TBL] [Abstract][Full Text] [Related]
57. Time for food: The impact of diet on gut microbiota and human health. Zhang N; Ju Z; Zuo T Nutrition; 2018; 51-52():80-85. PubMed ID: 29621737 [TBL] [Abstract][Full Text] [Related]
58. Bacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additives. Zou L; Spanogiannopoulos P; Pieper LM; Chien HC; Cai W; Khuri N; Pottel J; Vora B; Ni Z; Tsakalozou E; Zhang W; Shoichet BK; Giacomini KM; Turnbaugh PJ Proc Natl Acad Sci U S A; 2020 Jul; 117(27):16009-16018. PubMed ID: 32571913 [TBL] [Abstract][Full Text] [Related]
59. Hypromellose - A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery. Mašková E; Kubová K; Raimi-Abraham BT; Vllasaliu D; Vohlídalová E; Turánek J; Mašek J J Control Release; 2020 Aug; 324():695-727. PubMed ID: 32479845 [TBL] [Abstract][Full Text] [Related]
60. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]